Showing 121-130 of 325 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Identifying regulators of primary human beta cell survival and proliferation | The Regents of the University of California, San Francisco | Rebecca Lee | Cures | 01-March-2024 to 28-February-2027 | $235,025.00 |
| Allogeneic hypoimmunogenic Pancreatic Islets for Treatment of Diabetes in the Intra-Muscular Site | The Regents of the University of California, San Francisco | Tobias Deuse | Cures | 01-August-2024 to 31-July-2026 | $799,998.40 |
| Investigating MAFA governed mechanisms underlying β-cell functional maturation and dysfunction using hPSC-derived β-cells | The Regents of the University of California, San Francisco | Veronica Cochrane | Cures | 01-July-2024 to 28-February-2027 | $231,222.03 |
| Prediction of Cancer Immunotherapy Precipitated Autoimmune Diabetes | The Regents of the University of California, San Francisco | Zoe Quandt | Cures | 01-March-2025 to 28-February-2030 | $1,000,000.00 |
| Antigen-specific immunotherapies based on ignored ß-cell antigen determinants. | The Regents of the University of California, Los Angeles | Daniel Kaufman | Cures | 01-October-2024 to 30-September-2026 | $573,101.00 |
| Multiplex in vivo imaging of the dynamics of immune-mediated rejection of allogenic islet grafts | The Regents of the University of California, Los Angeles | Oluwatayo Ikotun | Cures | 01-February-2024 to 31-January-2027 | $749,996.25 |
| Network-based Systems Biology for T1D Drug Repositioning | The Regents of the University of California, Los Angeles | Xia Yang | Improving Lives | 01-May-2021 to 30-November-2025 | $780,961.09 |
| Investigation of novel local immunomodulating strategies to enhance islet transplantation for T1D | The Methodist Hospital Research Institute | Alessandro Grattoni | Cures | 01-July-2022 to 30-June-2026 | $962,995.99 |
| Prevascularized encapsulation platform with local immunosuppression for Islet transplantation | The Methodist Hospital Research Institute | Alessandro Grattoni | Cures | 01-August-2021 to 31-January-2026 | $660,000.00 |
| Tolerance inducing NanoLymph for in vivo generation of islet autoantigen-specific regulatory T cells | The Methodist Hospital Research Institute | Ying Xuan Chua | Cures | 01-April-2025 to 31-March-2026 | $200,000.00 |